Cornerstone Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Cornerstone Therapeutics, Inc. 's ( CRTX ) share price has entered into oversold territory with a stochastic value of 10.1244. The Zacks Consensus Estimate on the company's earnings for December 2012 increased by 93 cents over the past month to 97 cents per share. Cornerstone Therapeutics, Inc. is a Zacks #1 Rank ("Strong Buy") company.


CORNERSTONE THR (CRTX): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: CRTX

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by